Today we announced our partnership with bioMérieux, a world leader in the field of in vitro diagnostics, to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests.
bioMérieux is the latest company to join a stellar group of life science companies leveraging our proven, compliant BrightInsight Platform® as the foundation for their transformational software as a medical device (SaMD) and digital health solutions.
In vitro diagnostics (IVD) are crucial to healthcare decision making—between 60% and 70% of medical decisions are made based on the results of IVD testing. To help clinicians optimize insights from high-value diagnostics, bioMérieux will leverage the compliant BrightInsight Platform and BrightInsight Disease Management Solution to launch a digital solution for diagnostics. bioMérieux’s Clinical Digital Solution will launch first in the U.S., with a planned global expansion.
As healthcare providers are increasingly charged with delivering better patient outcomes at a lower total cost of care, it is critical that clinicians leverage the insights delivered by high-value diagnostics in a timely, optimal manner. The bioMérieux Clinical Digital Solution will address this need by improving clinical workflows, contextualizing disease awareness and ultimately enabling a more holistic patient view to support clinicians in making actionable, informed decisions.
The bioMérieux Clinical Digital Solution for diagnostics will include clinical decision support tools used in the ICU to assess risk and help reduce incidence of preventable diseases.
“As a global organization, we need a partner with a global footprint and platform,” said Marc Bonnet, Senior Vice President, Global Health Data Insights at bioMérieux. “BrightInsight’s Disease Management Solution is scalable and configurable to the regulatory, privacy and security requirements of myriad healthcare markets. We look forward to working with Brightinsight to bring innovative and needed digital solutions to market.”
BrightInsight replaces the need for lengthy and complex ‘build from scratch’ implementations by offering configurable software solutions and a proven platform built on Google Cloud under a Quality Management System to support global security, privacy and regulatory requirements. When building digital health products on the BrightInsight Platform, compliance is future-proofed as intended use changes scale across geographies.
We are honored to partner with bioMérieux to support the development of their Clinical Digital Solution for diagnostics, and proud to have the compliant BrightInsight Platform serve as the foundation for their transformational digital health solutions.